10x Genomics, Inc. Foreign Currency Transaction Gain Loss Realized After Tax
10x Genomics, Inc. (TXG) reported Foreign Currency Transaction Gain Loss Realized After Tax of -$400.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossRealizedAfterTax · last filed 2026-08-07
- 10x Genomics, Inc. foreign currency transaction gain loss realized after tax for the quarter ending 2026-06-30 was -$400.00K, a 117.39% decline year-over-year.
- 10x Genomics, Inc. foreign currency transaction gain loss realized after tax for the quarter ending 2026-03-31 was $800.00K.
- 10x Genomics, Inc. foreign currency transaction gain loss realized after tax for the quarter ending 2025-09-30 was -$600.00K, a 146.15% decline year-over-year.
- 10x Genomics, Inc. foreign currency transaction gain loss realized after tax for the quarter ending 2025-06-30 was $2.30M.
| Period end | Foreign Currency Transaction Gain Loss Realized After Tax 3 month | Foreign Currency Transaction Gain Loss Realized After Tax 6 month | Foreign Currency Transaction Gain Loss Realized After Tax 9 month |
|---|---|---|---|
| 2026-06-30 | -$400.00K 10-Q · filed 2026-08-07 | -$1.10M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $800.00K 10-Q · filed 2026-05-08 | ||
| 2025-09-30 | -$600.00K 10-Q · filed 2025-11-07 | $1.70M derived: sum of 2 quarters · filed 2026-08-07 | $3.10M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $2.30M 10-Q · filed 2026-08-07 | $3.70M 10-Q · filed 2026-08-07 | |
| 2025-03-31 | -$1.50M 10-Q · filed 2026-05-08 | ||
| 2024-09-30 | $1.30M 10-Q · filed 2025-11-07 | $1.20M derived: sum of 2 quarters · filed 2025-11-07 | $300.00K 10-Q · filed 2025-11-07 |
| 2024-06-30 | -$100.00K 10-Q · filed 2025-08-08 | -$1.00M 10-Q · filed 2025-08-08 | |
| 2024-03-31 | $1.00M 10-Q · filed 2025-05-09 |